Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA: 600566)
27.54
-0.77 (-2.72%)
Sep 6, 2024, 3:00 PM CST
Hubei Jumpcan Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 6,476 | 7,738 | 4,819 | 3,819 | 2,959 | 2,285 | Upgrade
|
Trading Asset Securities | 5,166 | 3,178 | 3,045 | 1,675 | 1,258 | 190 | Upgrade
|
Cash & Short-Term Investments | 11,642 | 10,916 | 7,863 | 5,494 | 4,217 | 2,475 | Upgrade
|
Cash Growth | 18.41% | 38.82% | 43.13% | 30.28% | 70.40% | 55.95% | Upgrade
|
Accounts Receivable | 1,826 | 2,782 | 2,850 | 2,183 | 2,032 | 2,055 | Upgrade
|
Other Receivables | 13.39 | 14.99 | 17.2 | 11.98 | 10.33 | 10.66 | Upgrade
|
Receivables | 1,840 | 2,797 | 2,867 | 2,195 | 2,042 | 2,065 | Upgrade
|
Inventory | 697.64 | 490.08 | 391.48 | 375.59 | 278.42 | 338.47 | Upgrade
|
Other Current Assets | 40.72 | 32.5 | 54.23 | 58.34 | 38.13 | 33 | Upgrade
|
Total Current Assets | 14,220 | 14,235 | 11,177 | 8,123 | 6,576 | 4,912 | Upgrade
|
Property, Plant & Equipment | 2,821 | 2,922 | 2,856 | 3,034 | 3,141 | 3,018 | Upgrade
|
Long-Term Investments | 426.73 | 393.97 | 332.34 | 328.44 | 155.33 | 106.62 | Upgrade
|
Goodwill | 167.3 | 167.3 | 167.3 | 167.3 | 167.3 | 167.3 | Upgrade
|
Other Intangible Assets | 298.24 | 305.01 | 320.62 | 280.04 | 283.84 | 335.83 | Upgrade
|
Long-Term Deferred Tax Assets | 32.16 | 45.45 | 62.16 | 57.32 | 42.62 | 38.3 | Upgrade
|
Long-Term Deferred Charges | 10.85 | 11.91 | 3.87 | 13.19 | 23.67 | 4.41 | Upgrade
|
Other Long-Term Assets | 72.64 | 62.16 | 62.14 | 127.96 | 126.51 | 82.5 | Upgrade
|
Total Assets | 18,050 | 18,144 | 14,981 | 12,131 | 10,516 | 8,665 | Upgrade
|
Accounts Payable | 1,779 | 2,141 | 1,505 | 945.77 | 452.52 | 436.09 | Upgrade
|
Accrued Expenses | 153.46 | 246.62 | 350.39 | 242.7 | 207.74 | 191.44 | Upgrade
|
Short-Term Debt | 1,350 | 1,088 | 400 | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | 627.55 | - | - | Upgrade
|
Current Portion of Leases | 1.1 | 1.06 | 0.44 | 1.55 | - | - | Upgrade
|
Current Income Taxes Payable | 67.09 | 182.62 | 106.09 | 43.71 | 69.64 | 69.39 | Upgrade
|
Current Unearned Revenue | 14.67 | 17.25 | 49.14 | 19.34 | 8.03 | 15.63 | Upgrade
|
Other Current Liabilities | 959.45 | 915.86 | 1,016 | 919.98 | 1,229 | 1,127 | Upgrade
|
Total Current Liabilities | 4,325 | 4,592 | 3,427 | 2,801 | 1,967 | 1,840 | Upgrade
|
Long-Term Debt | - | - | - | - | 602.58 | 576.15 | Upgrade
|
Long-Term Leases | 1.22 | 1.43 | 0.2 | 1.02 | - | - | Upgrade
|
Long-Term Unearned Revenue | 68.45 | 71.43 | 78.19 | 84.63 | 90.67 | 58.29 | Upgrade
|
Long-Term Deferred Tax Liabilities | 123.28 | 109.28 | 122.05 | 112.38 | 90.72 | 82.97 | Upgrade
|
Other Long-Term Liabilities | 0.77 | 0.82 | 1.06 | 1.35 | 1.67 | 2.9 | Upgrade
|
Total Liabilities | 4,519 | 4,775 | 3,629 | 3,000 | 2,753 | 2,560 | Upgrade
|
Common Stock | 452.74 | 452.74 | 452.74 | 436.27 | 436.26 | 400.24 | Upgrade
|
Additional Paid-In Capital | 4,009 | 3,999 | 3,984 | 3,148 | 3,114 | 1,766 | Upgrade
|
Retained Earnings | 9,151 | 9,010 | 6,998 | 5,431 | 4,112 | 3,837 | Upgrade
|
Treasury Stock | -104.52 | -111.97 | -97.18 | - | - | - | Upgrade
|
Comprensive Income & Other | - | - | - | 100.81 | 100.87 | 100.89 | Upgrade
|
Total Common Equity | 13,508 | 13,349 | 11,337 | 9,117 | 7,763 | 6,104 | Upgrade
|
Minority Interest | 22.41 | 19.42 | 15.14 | 14.17 | - | - | Upgrade
|
Shareholders' Equity | 13,531 | 13,369 | 11,352 | 9,131 | 7,763 | 6,104 | Upgrade
|
Total Liabilities & Equity | 18,050 | 18,144 | 14,981 | 12,131 | 10,516 | 8,665 | Upgrade
|
Total Debt | 1,353 | 1,090 | 400.65 | 630.12 | 602.58 | 576.15 | Upgrade
|
Net Cash (Debt) | 10,289 | 9,826 | 7,463 | 4,864 | 3,615 | 1,899 | Upgrade
|
Net Cash Growth | 11.03% | 31.67% | 53.43% | 34.56% | 90.37% | 83.58% | Upgrade
|
Net Cash Per Share | 11.20 | 10.72 | 8.22 | 5.40 | 4.33 | 2.33 | Upgrade
|
Filing Date Shares Outstanding | 921.81 | 921.81 | 921.82 | 888.27 | 888.26 | 814.82 | Upgrade
|
Total Common Shares Outstanding | 921.81 | 921.81 | 921.82 | 888.27 | 888.26 | 814.82 | Upgrade
|
Working Capital | 9,895 | 9,644 | 7,749 | 5,322 | 4,609 | 3,072 | Upgrade
|
Book Value Per Share | 14.65 | 14.48 | 12.30 | 10.26 | 8.74 | 7.49 | Upgrade
|
Tangible Book Value | 13,043 | 12,877 | 10,849 | 8,670 | 7,312 | 5,601 | Upgrade
|
Tangible Book Value Per Share | 14.15 | 13.97 | 11.77 | 9.76 | 8.23 | 6.87 | Upgrade
|
Buildings | 2,938 | 2,911 | 2,455 | 2,473 | 2,362 | 1,815 | Upgrade
|
Machinery | 1,689 | 1,685 | 1,644 | 1,566 | 1,488 | 1,328 | Upgrade
|
Construction In Progress | 192 | 186.98 | 352.15 | 322.17 | 364.89 | 725.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.